5-azacytidine treatment results in myelodysplastic syndrome

被引：0
|
作者：
Bakanay, S. M. [1 ]
Karakilic, E. [1 ]
Civriz-Bozdag, S. [1 ]
Arat, M. [1 ]
Ozcan, M. [1 ]
Gurman, G. [1 ]
Ilhan, O. [1 ]
Beksac, M. [1 ]
Konuk, N. [1 ]
Arslan, O. [1 ]
机构：
[1] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18003
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bone Marrow Levels of PARP1 mRNA Predict Response to Treatment with 5-Azacytidine in Patients with Myelodysplastic Syndrome
    Diamantopoulos, Panagiotis Theodorou
    Kodandreopoulou, Elina
    Symeonidis, Argiris S.
    Kotsianidis, Ioannis
    Pappa, Vassiliki
    Galanopoulos, Athanasios
    Dimou, Maria
    Christopoulou, Georgia
    Zervakis, Konstantinos
    Solomou, Elena E.
    Kyrtsonis, Marie-Christine
    Rougala, Niki
    Siakantaris, Marina
    Vassilakopoulos, Theodoros
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    BLOOD, 2017, 130
  • [42] Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome
    Sohlberg, Ebba
    Pfefferle, Aline
    Andersson, Sandra
    Baumann, Bettina C.
    Hellstrom-Lindberg, Eva
    Malmberg, Karl-Johan
    ONCOTARGET, 2015, 6 (33) : 34178 - 34190
  • [43] Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
    Diamantopoulos, Panagiotis T.
    Pappa, Vasiliki
    Symeonidis, Argiris
    Kotsianidis, Ioannis
    Galanopoulos, Athanasios
    Papadaki, Helen
    Anagnostopoulos, Achilles
    Vassilopoulos, George
    Zikos, Panagiotis
    Hatzimichael, Eleftheria
    Papaioannou, Maria
    Megalakaki, Aekaterini
    Kotsopoulou, Maria
    Repousis, Panagiotis
    Dimou, Maria
    Solomou, Eleni
    Pontikoglou, Charalampos
    Kyriakakis, Georgios
    Tsokanas, Dimitrios
    Papoutselis, Menelaos-Konstantinos
    Papageorgiou, Sotirios
    Kourakli, Alexandra
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02): : 114 - 121
  • [44] 5-azacytidine in the treatment of Greek patients with higher-risk myelodysplastic syndromes. An overview
    Zervakis, K.
    Diamantopoulos, P.
    Papadopoulou, V.
    Iliakis, T.
    Mpakarakos, P.
    Kalala, F.
    Giannakopoulou, N.
    Rougkala, N.
    Galanopoulos, A.
    Variami, E.
    Dimitrakopoulou, A.
    Viniou, N.
    LEUKEMIA RESEARCH, 2013, 37 : S159 - S159
  • [45] ENZYMATIC-SYNTHESIS OF 5-AZACYTIDINE 5'-TRIPHOSPHATE FROM 5-AZACYTIDINE
    LEE, TT
    MOMPARLER, RL
    ANALYTICAL BIOCHEMISTRY, 1976, 71 (01) : 60 - 67
  • [46] INTERIM ANALYSIS OF THE USE OF 5-AZACYTIDINE FOR TREATMENT OF MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKAEMIA WITH CHROMOSOME 7 OR COMPLEX CYTOGENETIC ABNORMALITIES
    Yiu, R.
    Lim, Z. Y.
    Ho, A. Y.
    Ireland, R.
    Marsh, J.
    Pasipanodya, P.
    Hayden, J.
    Mufti, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 130 - 130
  • [47] Identification of genes that predict the response to chemotherapy with 5-azacytidine in myelodysplastic syndromes
    Matsumoto, Taichi
    Murakami, Yuichi
    Katsuchi, Daisuke
    Kuwano, Michihiko
    Ono, Mayumi
    CANCER SCIENCE, 2023, 114 : 1261 - 1261
  • [48] The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome
    Costantini, Benedetta
    Kordasti, Shahram Y.
    Kulasekararaj, Austin G.
    Jiang, Jie
    Seidl, Thomas
    Abellan, Pilar Perez
    Mohamedali, Azim
    Thomas, Nicolas Shaun B.
    Farzaneh, Farzin
    Mufti, Ghulam J.
    HAEMATOLOGICA, 2013, 98 (08) : 1196 - 1205
  • [49] Treatment of Poor Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia with a Combination of 5-Azacytidine and Valproic Acids
    Kuendgen, Andrea
    Bug, Gesine
    Ottmann, Oliver G.
    Haase, Detlef
    Hildebrandt, Barbara
    Habersang, Kerstin
    Dienst, Ariane
    Haas, Rainer
    Germing, Ulrich
    Gattermann, Norbert
    BLOOD, 2008, 112 (11) : 1245 - 1245
  • [50] 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
    A Czibere
    I Bruns
    N Kröger
    U Platzbecker
    J Lind
    F Zohren
    R Fenk
    U Germing
    T Schröder
    T Gräf
    R Haas
    G Kobbe
    Bone Marrow Transplantation, 2010, 45 : 872 - 876
12345